Ostrowski, M., Jo, Y., Gebrael, G., Ozay, Z. I., Nandakumar, V., Chehade, C. H., Hooper, G., Hardy, R. T., Goel, K., Campbell, P., Nussenzveig, R. H., Li, H., Thomas, V. M., Maughan, B. L., Swami, U., Agarwal, N. (2026). Real-world comparative effectiveness of first-line (1L) cabozantinib (C) versus cabozantinib with nivolumab (C+N) in patients (pts) with metastatic papillary renal cell carcinoma (mPRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.461